Active Pharmaceutical Ingredients (API) Market Size to Reach USD 105780 Million by 2027 at a CAGR of 6.6% | Valuates Reports

India - English

News provided by

Feb 23, 2022, 08:00 ET

BANGALORE, India, Feb. 23, 2022 /PRNewswire/ -- The Global API Market is Segmented by Type (Synthetic APIs, Biotech APIs), by Application (Cardiovascular, CNS, Oncology, Respiratory, Genitourinary/Hormonal Drugs, Rheumatology, Diabetes): Opportunity Analysis and Industry Forecast, 2021–2028. It is published in Valuates Reports under the Pharmaceuticals & Biotech Category.

The global Active Pharmaceutical Ingredients Market was valued at USD 67700 Million in 2020 and it is expected to reach USD 105780 Million by the end of 2027, growing at a CAGR of 6.6% during 2021-2027.

Major Factors Driving the Growth of Active Pharmaceutical Ingredients Industry:

The active pharmaceutical ingredients market is expected to grow at a rapid rate over the forecast period, owing to an increase in the number of biosimilars and an increase in the cases of various chronic diseases.

Furthermore, factors such as increased drug R&D and biopharmaceutical uptake are expected to propel the API market forward.

Get Your Sample On API Market

TRENDS INFLUENCING THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET GROWTH:

Chronic diseases such as diabetes, coronary artery disease, chronic obstructive pulmonary disease (COPD), asthma, hepatitis, arthritis, and cancer have increased significantly in major regions around the world over the last few decades. This is due to an increase in the global geriatric population, changing lifestyles, and dietary changes as a result of rapid urbanization. APIs are a type of drug that is used to treat and prevent a variety of chronic diseases. As a result, the active pharmaceutical ingredients market is expected to grow as the number of chronic diseases rises.

The outbreak of the COVID-19 pandemic in 2020 had a positive impact on the active pharmaceutical ingredient market, as countries and major players are producing large quantities of ingredients to meet the demand for COVID 19 treatment. As a result of the COVID-19 outbreak, drug companies have redirected their models to focus on a larger group of patients.

During the forecast period, the emerging biosimilars market is expected to propel the active pharmaceutical market even further. A biosimilar is a biological product that is very similar to a reference biologic but does not differ clinically in terms of safety, purity, or potency.

The Active Ingredients market is expected to grow due to increased R&D for new drugs to address rising diseases. The API manufacturer must develop a new chemical process in order to improve industrial efficiency, which necessitates a significant technological contribution from the API manufacturer. It is therefore critical for the API manufacturer to have a cutting-edge Research & Development (R&D) facility, allowing for the transition from laboratory scale to pilot plant, and then to full industrial scale, while maintaining the characteristics required by the pharmaceutical industry for drug production and distribution. In addition, the shift in the trend toward precision medicine is expected to provide lucrative growth opportunities for API market participants.

Browse The Table Of Contents And List Of Figures At Active Pharmaceutical Ingredients Market Report

ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE:

Based on type, Synthetic APIs are expected to be the most lucrative segment. This can be attributed to increased raw material availability and simplified synthesis protocols for these molecules.

Based on region, North America is expected to be the most lucrative segment. The growing incidence of preventable chronic diseases, increased government focus on generic drugs, rising demand for biologics and specialty drugs, and technological advancements in API manufacturing processes are all factors contributing to North America's market growth.

Get Regional Data On Active Pharmaceutical Ingredients Industry

Key Players

Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy's Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC.

Inquire for Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-31E2189/Covid_19_Impact_on_Global_Active_Pharmaceutical_Ingredients_API

Buy Now for Single User + Covid-19 Impact: https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-31E2189&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

- Global Animal Health Active Pharmaceutical Ingredients Market Insights and Forecast to 2028

- Global Penicillin Active Pharmaceutical Ingredients Market Outlook 2022

- Global HPAPI (High Potency Active Pharmaceutical Ingredients) Market Insights and Forecast to 2028

- China Heparin Active Pharmaceutical Ingredients Market Report & Forecast 2021-2027

- Global and United States Oxaprozin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

- Global and China Generic Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

- Global and China Diclofenac Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

- Global and Japan Aspirin Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

- Global and China Antipyretic Analgesic Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

- Global and Japan Sterile Active Pharmaceutical Ingredients Market Insights, Forecast to 2027

Click here to see related reports on Pharmaceutical Ingredients Market

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:

Valuates Reports
[email protected]
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports

SOURCE Valuates Reports